ctdna, a biomarker of residual disease and tumor response in gastrointestinal cancers
Published 4 years ago • 201 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
8:45
ctdna as a novel biomarker for mrd in crc
-
3:30
ctdna as an mrd biomarker for nsclc
-
0:45
the emerging role of ctdna in cancer diagnostics
-
1:09
ctdna mrd as a biomarker for solid tumors
-
3:16
the utility of ctdna in colorectal cancer management
-
28:57
circulating tumor dna as an immunotherapy biomarker
-
1:02
galaxy: ctdna as a prognostic biomarker in resected colorectal cancer
-
6:22
utilising ctdna in oncology
-
0:31
applications of ctdna in the management of colorectal cancer
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
7:53
ctdna mrd detection from plasma and urine in colorectal cancer
-
2:13
ongoing clinical trials on using ctdna results to guide gi cancer management
-
2:06
applications of ctdna in oncology
-
4:26
fundamentals of ctdna
-
3:44
ctdna as a diagnostic, prognostic, and predictive biomarker for lung cancer
-
3:00
liquid biopsy: future directions for ctdna in nsclc
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference
-
1:53
the clinical use of ctdna as a biomarker in tnbc